Search details
1.
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide-treated myeloma patients.
Hematol Oncol
; 41(3): 424-433, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36426594
2.
Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myeloma.
Cancer Sci
; 111(4): 1333-1343, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32061138
3.
Specific dermoscopic findings in glomeruloid haemangioma for diagnosis of POEMS syndrome.
J Eur Acad Dermatol Venereol
; 2023 Dec 08.
Article
in English
| MEDLINE | ID: mdl-38069554
4.
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.
Int J Hematol
; 110(1): 119-123, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-30879266
5.
Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice.
J Neurotrauma
; 35(13): 1481-1494, 2018 07 01.
Article
in English
| MEDLINE | ID: mdl-29316834
6.
Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
Cancer Chemother Pharmacol
; 58(3): 348-53, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-16331495
7.
Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.
Cancer Chemother Pharmacol
; 64(4): 715-21, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19153736
Results
1 -
7
de 7
1
Next >
>>